Veradermics holder proposes $37.6M share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Veradermics, Inc. (MANE) 10% stockholder Longitude Venture Partners V, L.P. gave notice of a proposed sale of 250,000 common shares, with an approximate sale date of November 11, 2026 and an aggregate market value of $37,595,000. An acquisition entry records a cash private placement from the issuer on October 14, 2025. A separate three-month sales table lists Longitude 103.8 East, L.P. as having sold 250,000 common shares on November 11, 2026, for gross proceeds of $37,595,000. Cristiana Oliveira signed the notice.
Key Figures
Key Terms
10% Stockholder regulatory
Private Placement financial
Aggregate Market Value financial
Gross Proceeds financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.